Project Details
| Short title | VEGA |
|---|---|
| Acronym | VEGA |
| Status | Finished |
| Effective start/end date | 24/09/19 → 11/07/24 |
A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
- Leong, Rupert (Primary Chief Investigator)
- Butala, Radhika (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Other